posted on Jan, 23 2012 @ 11:43 AM
reply to post by freakjive
Well do you blame them? Clinical trials cost millions of dollars, rising as high as $1 billion, and 10-15 years to complete. Even if DCA pans out,
there is no profit at all to be gained from it - which is the antithesis of a business.
It would make far more sense for independent or academic laboratories to go into researching this potential lead (and I'm pretty sure a few
independent trials by academic researchers are underway too!)